Chemical Complementarity of Breast Cancer Resident, T-Cell Receptor CDR3 Domains and the Cancer Antigen, ARMC3, is Associated With Higher Levels of Survival and Granzyme Expression.

Pakasticali, Nagehan; Chobrutskiy, Andrea; Patel, Dhruv N; Hsiang, Monica; Zaman, Saif; Cios, Konrad J; Blanck, George; Chobrutskiy, Boris I

Pakasticali, Nagehan; Chobrutskiy, Andrea; Patel, Dhruv N; Hsiang, Monica; Zaman, Saif; Cios, Konrad J; Blanck, George; Chobrutskiy, Boris I.

Afiliación

Pakasticali N; Department of Pathology, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Chobrutskiy A; Department of Pediatrics, Oregon Health and Science University Hospital, Portland, OR, USA.
Patel DN; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Hsiang M; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Zaman S; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Cios KJ; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Blanck G; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Chobrutskiy BI; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

Cancer Inform ; 22: 11769351231177269, 2023.

Article en En | MEDLINE | ID: mdl-37313373

Palabras clave

ARMC3; Breast cancer T-cell receptors; chemical complementarity scoring; survival distinctions

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Inform Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google